Skip to main content

Table 2 Overall frequency of antimicrobial resistant E. coli from community-onset vs healthcare-onset/associated bacteriuria episodes, 2014–2020

From: Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

 

Number of antimicrobial resistant E. coli bacteriuria episodes, n (%)

NIT

T/S

CIP

ESBL

Any AMR

MDR

Community onset*

129 (2)

2691 (35)

1537 (20)

623 (8)

4719 (61)

1306 (16.85)

Healthcare onset/associated**

42 (3)

544 (43)

496 (39)

308 (24)

911 (71)

401 (31.30)

  1. Data from a public healthcare system including inpatient and outpatient services and a skilled nursing facility; NIT: nitrofurantoin, T/S: trimethoprim/sulfamethoxazole, CIP: ciprofloxacin, ESBL: extended-spectrum beta-lactamase, AMR: antimicrobial resistance, MDR: multidrug resistance. Not all ESBL-E. coli samples were tested for NIT, T/S or CIP
  2. *7751 isolates tested for ESBL, Any AMR, or MDR, 7737 for T/S and CIP, 7736 tested for NIT
  3. **1277 isolates tested for ESBL, Any AMR, or MDR, 1274 for T/S and CIP, 1273 for NIT
Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us